DARPA’s Biological Technologies Office is hosting an online-only Proposers Day webinar to provide information to potential applicants on the structure and objectives of the new Biostasis program. Biostasis aims to extend the time for lifesaving medical treatment following traumatic injury or acute infection by developing novel, non-thermal, molecular interventions to reversibly slow or pause the functions of living cells and preserve their viability. Additional details are available at https://go.usa.gov/xnzqE. Full program details will be made available in a forthcoming Broad Agency Announcement posted to the Federal Business Opportunities website.
To register, visit https://events.sa-meetings.com/BiostasisProposersDay. Registration will close on Friday, March 16, 2018, at 12:00 PM EDT or when capacity is reached.
Please address administrative questions to DARPA-SNemail@example.com, and refer to the Biostasis webinar (DARPA-SN-18-36) in all correspondence.
DARPA hosts Proposers Days to provide potential performers with information on whether and how they might respond to the Government’s research and development solicitations and to increase efficiency in proposal preparation and evaluation. Therefore, the Biostasis Proposers Day is open only to registered potential applicants, and not to the media or general public.
You are now leaving the DARPA.mil website that is under the control and
management of DARPA. The appearance of hyperlinks does not constitute
endorsement by DARPA of non-U.S. Government sites or the information,
products, or services contained therein. Although DARPA may or may not
use these sites as additional distribution channels for Department of
Defense information, it does not exercise editorial control over all of
the information that you may find at these locations. Such links are
provided consistent with the stated purpose of this website.
After reading this message, click to continue